MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology
Version of Record online: 19 DEC 2010
© 2010 Japanese Cancer Association
Volume 102, Issue 3, pages 522–529, March 2011
How to Cite
Yamada, Y., Enokida, H., Kojima, S., Kawakami, K., Chiyomaru, T., Tatarano, S., Yoshino, H., Kawahara, K., Nishiyama, K., Seki, N. and Nakagawa, M. (2011), MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Science, 102: 522–529. doi: 10.1111/j.1349-7006.2010.01816.x
- Issue online: 17 FEB 2011
- Version of Record online: 19 DEC 2010
- Accepted manuscript online: 1 DEC 2010 10:55AM EST
- (Received September 8, 2010/Revised November 18, 2010/Accepted November 27, 2010/Accepted manuscript online December 1, 2010/Article first published online December 19, 2010)
Fig. S1. Stem-loop PCR analysis of miR-96 and miR-183 expression in urine samples from 100 urothelial carcinoma (UC) patients, 49 healthy controls (HC) (median age, 36 years) and 34 older healthy controls (HC) (median age, 74.5 years).
Table S1. Patient’s characteristics of clinical specimens.
Table S2. Entire sequence used for each microRNA transfection.
Table S3. MicroRNA detection in a patient who had a urine cytology test.
|CAS_1816_sm_FigureS1.TIF||563K||Supporting info item|
|CAS_1816_sm_TableS1.doc||61K||Supporting info item|
|CAS_1816_sm_TableS2.doc||29K||Supporting info item|
|CAS_1816_sm_TableS3.doc||144K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.